Page last updated: 2024-10-31

moclobemide and Sleep Apnea Syndromes

moclobemide has been researched along with Sleep Apnea Syndromes in 1 studies

Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.

Sleep Apnea Syndromes: Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lang, FU1
Hösch, H1
Seibert, H1
Klug, R1
Köppler, D1
Jäger, M1

Other Studies

1 other study available for moclobemide and Sleep Apnea Syndromes

ArticleYear
[Obstructive sleep apnoea syndrome as the cause of atypical depression].
    Fortschritte der Neurologie-Psychiatrie, 2011, Volume: 79, Issue:9

    Topics: Adult; Antidepressive Agents; Body Weight; Continuous Positive Airway Pressure; Depressive Disorder;

2011